INTRODUCTION
Pterostilbene (PTS) (Figure 1 ) belongs to the group of phytoalexins produced by plant 1 also found in red wine is a dimethylated analogue of resveratrol. It is found in blueberries, grapes and in age-old darakchasava, an ayurvedic medicine from India 2 and in the tree species Pterocarpus marsupium and Guibourtia tessmanii. [3] [4] [5] [6] [7] [8] It is believed to exhibit anti-cancer activity, [9] [10] [11] anti-fungal activity 12 anti-diabetic and antioxidant actions. Three liquid chromatographic methods were developed for the determination of Pterostilbene in rat plasma with fluorescence detection 17 dragon blood 18 and rat plasma in gradient mode 19 and no spectrophotometric method has been developed for the assay of Pterostilbene in pharmaceutical formulations. Currently the authors have proposed three simple, rapid, precise and robust validated spectrophotometric methods (derivative and difference spectroscopy) for the determination of PTS in capsules.
MATERIALS AND METHODS

Chemicals and Reagents
Pterostilbene standard (>99.0% purity) was obtained from Oxford laboratory, India. Sodium hydroxide, methanol and boric acid were obtained from Merck (India). All chemicals were of analytical grade and used as received. Pterostilbene is available as capsules with brand names such as PTEROSTILBENE (Source Naturals Inc. (Canada); Label claim: 50 mg) (Brand I), PTEROSTILBENE (Absorb Health (North Carolina); Label claim: 100 mg) (Brand II). Pterostilbene is procured from Booyahchicago, Delhi, India.
Instrumentation
A double beam UV-VIS spectrophotometer (UV-1800, Shimadzu) loaded with spectra manager software UV Probe was employed with spectral band width of 1 nm and wavelength accuracy of ± 0.3 nm with a pair of 10 mm matched quartz cells. 400 nm to 200 nm the wavelength range was selected for scanning with medium scanning speed.
Procedure Preparation of Pterostilbene stock and working standard solutions
Pterostilbene stock solution (1000 μg/ml) was prepared by dissolving 25 mg of PTS in methanol in a 25 ml volumetric flask. Working solutions were prepared from the stock solution with on dilution with sodium hydroxide, methanol and borate buffer as per the requirement for method A, B and C respectively.
Preparation of borate buffer (pH-9.0)
6.20gm of boric acid was dissolved in 500ml of distilled water, adjusted to pH 9.0 with 0.1 M sodium hydroxide (about 41.5ml) and diluted to 1000ml with distilled water.
Derivative spectroscopic methods (Method A and Method B)
A series of Pterostilbene solutions 0.1-25 μg/ml and 1-25 μg/ml were prepared from the stock solution by diluting with 0.1 N NaOH and methanol respectively and scanned (200-400 nm) for method A and method B. The resulting zero order absorption spectra obtained were converted in to first derivative spectra by the inbuilt software of the instrument.
Differential spectroscopic method (Method C)
A series of Pterostilbene solutions 0.1-20 μg/ml were prepared from the stock solution by diluting with 0.1 N NaOH and borate buffer separately. The solutions prepared in sodium hydroxide were used in reference Annapurna et al.: Derivative and Differential Spectrophotometric Methods for the Determination of Pterostilbene cuvette as blank and the same concentration solutions prepared in borate buffer were scanned by keeping them in the sample cuvette for method C.
Validation 20
Linearity
Method A First derivative spectrophotometric method was developed in sodium hydroxide solution for the determination of PTS. The zero order absorption spectra so obtained (0.1-25 μg/ml) was converted in to first derivative spectra by the inbuilt software of the instrument. The resulting derivative spectra show both maxima and minima at 332 nm and 369 nm but the magnitude of minima was selected for all the analytical calculations. A calibration curve was drawn by plotting the concentration of the drug solution on the x-axis and the corresponding minima values on the y-axis.
Method B
The first derivative spectra obtained for Pterostilbene drug solutions (1-25 μg/ml) show both maxima and minima at 283 nm and 342 nm but the maxima was selected for all the analytical calculations. A calibration curve was drawn by plotting the concentration of the drug solution on the x-axis and the corresponding maxima values on the y-axis.
Method C A series of Pterostilbene drug solutions (0.1-22 μg/ml) were prepared in sodium hydroxide and scanned (200-400 nm) against the solutions prepared in borate buffer of the same concentration and the difference absorption spectra was recorded. The difference absorption spectrum has shown minima at 353 nm and maxima at 294 nm and therefore the amplitude was selected for all the analytical calculations. A graph was drawn by plotting the concentration of the drug solutions on the x-axis and the corresponding amplitude values on y-axis.
Precision and accuracy
The intra-day and inter-day precision studies of the three methods were performed at three different concentration levels (10, 15 and 20 µg/ml) and on three different days respectively and the % RSD was calculated. The accuracy of the assay method was calculated at three different levels (80%, 100% and 120%) by the standard addition method and the percentage recoveries were calculated for method A, B and C with sodium hydroxide, methanol and borate buffer respectively.
Assay of marketed formulations (Capsules)
Twenty capsules of Pterostilbene were procured from the local pharmacy store and the contents were finely powdered and powder equivalent to 100 mg PTS was accurately weighed and dissolved in sodium hydroxide, methanol and borate buffer in a 100 ml volumetric flask separately and the contents of the flask were sonicated for 30 min and filtered for method A, B and C respectively. These solutions were diluted as per the requirement with the respective solvents and analysed.
RESULTS AND DISCUSSION
Three new analytical methods (two first derivative and one difference spectrophotometric method) have been developed for the determination of Pterostilbene using sodium hydroxide (Figure 2 ), methanol ( Figure 3 ) and borate buffer-sodium hydroxide ( Figure 4 ) for method A, B and C respectively. The minima, maxima and the amplitude were chosen for all the analytical calculations for method A, B and C respectively from the respective spectra. Pterostilbene shows linearity over the concentration range 0.1-25, 1-25 and 0.1-20 μg/ml (Table 1) 
CONCLUSION
The proposed validated derivative and differential spectrophotometric methods are simple, precise, accurate and can be applied for the determination of Pterostilbene in pharmaceutical formulations successfully.
